Molecular Diagnostics
Blood Test Could Predict Best Treatment for Lung Cancer
A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment. In most patients with SCLC, a metastatic, aggressive disease, the condition is initially chemosensitive, but then relapses with acquired chemoresistance. More...09 Dec 2016
Rare Genetic Variations Linked to Schizophrenia
Genetic variations that increase schizophrenia risk are rare, making it difficult to study their role and to overcome this. Recently, the genomes of more than 41,000 people have been analyzed in the largest study of its kind to date. More...09 Dec 2016
Genetic Testing Identifies High-Risk Subtype of Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is less common in adults than in children, but adults are far less likely to survive. Adults make up about 40% of the estimated 6,590 new cases of ALL identified annually in the USA. More...09 Dec 2016
Diagnostic Tool Designed for Familial Mediterranean Fever
A tool has been developed to diagnose Familial Mediterranean Fever (FMF) which is particularly common among populations originating from around Mediterranean Sea and this genetic disease is characterized by inflammation, fever and severe pain. More...08 Dec 2016
Successful Treatment of Enteritis Due to Newly Discovered Gene Mutation
Researchers report successful treatment of an adult patient with severe chronic autoimmune enteritis by using the drug Vedolizumab to target the effect on T-cell function of a mutation identified in the patient’s CTLA-4 gene. Vedolizumab may also help skin cancer patients with enteritis due to therapy with Ipilimumab. More...07 Dec 2016
Multiple Biopsies Recommended for Personalized Breast Cancer Treatments
Assessment of somatic mutations is becoming increasingly important for the management of cancer patients, but molecular heterogeneity occurs across many tumors. In breast cancer, there is major interest in the use of pre-surgical studies for assessing the biological effect of therapeutic agents. More...01 Dec 2016
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automated ELISA System
DS2 ELITE
New
Thyroid Test
Anti-Thyroid EIA Test
In Other News
Genetic Test Significantly Reduces Risk of Cardiovascular Events
Novel Urine Test Predicts High-Risk Cervical Cancer
Titin Gene Mutation Increases Risk of Heart Failure
Uncombable Hair Syndrome Genes Identified
Biomarker Identified for Aggressive Thyroid Cancer
Blood Test May Help Identify Fetal Alcohol Spectrum Disorders
Molecular Signature Identified for Aggressive Brain Tumor
Cytosponge Test Could Replace Uncomfortable Endoscopies
Software Platform Provides Capabilities for Somatic Variation Analysis
Gene Sets Identified May Predict Response to RA Therapies
Tumor Markers Reveal Lethality of Bladder Cancers
Identification of Gene Defects Helps Prostate Cancer Treatment
Prenatal Genetic Test Is Accurate Five Weeks into Pregnancy
Disease Genes Effect May Be Overcome by Other Gene Mutations
Vascular Development Gene Helps Protect Against Stroke Damage
Common Gene Sets Disrupted in Major Psychiatric Disorders
Early Childhood Screening Helps Prevent Heart Attacks
New Genetic Factors Linked to HPV-Related Cancers
Testing Method Clinically Ascertains Genetic Basis for Hypercholesterolemia
Gene Abnormality Found to Underlie Rare Neurological Disease
Non-Invasive Assay Improves Surveillance of Solid-Organ Transplants
Low Cost Method Examines Single Leukemic Cells
Commercial Molecular Assay Validated for Dengue Virus Outbreak
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
